Press Release Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering Aug 28
Press Release Kazia Therapeutics Reports 100% Clinical Benefit Rate in Initial Six Patients Treated for Advanced Triple-Negative Breast Cancer Aug 28